Why has THR been such a polarised area of science and policy – what could improve it?
Archives: Seminars
CLOSING KEYNOTE: Covid-19 and tobacco harm reduction: are there lessons from the pandemic for the way ahead?
At various points since early 2020 it has become apparent that there are similarities between some of the challenges faced in tobacco harm reduction research and policy and those we’ve encountered during the Covid-19 pandemic. Both involve using complex and often conflicting sources of data and evidence to inform public health interventions. Both have particular… Read more »
How tobacco harm reduction pragmatism has opened up opportunities for smokers facing severe disadvantage
The UK has both a strong history of embracing drug harm reduction approaches and regulatory tobacco control. This environment has created opportunities to help people who smoke who are facing severe and multiple disadvantage, through clinical or research initiatives. It has also provided a scientific environment in which researchers can explore the potential of harm… Read more »
The impact of the COVID-19 pandemic on e-cigarette and tobacco use in the UK
The COVID-19 pandemic led to strict lockdowns in the UK throughout 2020 and 2021, which impacted both access to tobacco-related services (e.g., Stop Smoking Services) as well as retail outlets (e.g., Vape Shops). Further, it is likely that the presence of a potentially deadly respiratory virus will have influenced smokers and vapers views on their… Read more »
Parents: The Untapped Resource for Balancing Cessation and Prevention Needs:
This presentation will discuss the potential for parents to be the untapped link between smoking cessation and prevention of youth use of e-cigarettes and other tobacco products. Although there is substantial evidence for the association of parental smoking and youth smoking, less is known about ripple effects of parental smoking cessation on youth tobacco and… Read more »
Introduction from the Chair
Shifting the Paradigm: Tobacco Control and Tobacco Harm Reduction are Scientifically Complementary Approaches to Reducing Illness and Saving Lives
The US Food and Drug Administration’s recent authorization of certain e-cigarettes and other non combustible tobacco products under its premarket tobacco products application process confirmed the agency’s understanding that e-cigarettes and other alternative nicotine-containing consumer products are significantly less harmful than tobacco products that are burned. The FDA determined that these products can be good… Read more »
PM BREAK
Panel discussion and live Q&A
Nicotine research in a politicised landscape – how do we maintain scientific integrity?
Greater Manchester is making smoking history: Meeting people where they are and not where we think they should be
Greater Manchester’s Making Smoking History strategy was launched in 2017 to tackle inequalities by reducing smoking prevalence across the population. Since then, it has helped to improve the health, wellbeing, and wealth of thousands of residents and their families and is currently leading the way for tobacco control in England. Campaigns have focused on hard… Read more »
Recent Comments